That the above two quotes are arguably truer now than at the time they were written is perhaps surprising. That this truth resonates equally for the authors who have experienced the two most recent respiratory infection pandemics (H1N1/09 influenza and coronavirus disease 2019 (COVID-19)) and the ongoing bias towards relatively small, uncontrolled treatment trials from very different…
This protocol describes the process of developing a performance-based toolkit to assess the key treatable traits of functioning in hospitalised patients with ECOPD in order…
Smoking cessation at lung cancer screening is viable and an excellent opportunity https://bit.ly/3TC0HAf
The ongoing French RAMSES cohort includes more than 2000 severe asthma patients, with differences in terms of phenotype and asthma care trajectories between secondary and…
This book is now available for pre-order. All pre-orders will be dispatched when the book is published in June 2024. Edited by Alexandra M. Nanzer, Peter…
Our growing understanding of how the epithelium and epithelial cytokines orchestrate airway remodelling in severe asthma is enabling the development of new therapies that may…
“Digital transformation is already happening. It’s not a question of if, but how.” The restrictions of the COVID-19 pandemic changed the landscape of digital healthcare…
The FIS assay generally indicates responsiveness to CFTR modulators, but it cannot discriminate between high and low responders within the F508del homozygous subjects. Higher FIS…
As part of the April issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Ritesh Agarwal…
Increased exposure to tree canopy around the place of residence at birth prevented the risk of childhood asthma development, but this protective effect can be…
Uptake of stop smoking support co-located within a lung cancer screening programme was high across a range of participant demographics and quit rates were in…
